Review




Structured Review

Sequenom massarray platform
Massarray Platform, supplied by Sequenom, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/massarray+methylation+detection/massarray+platform/ppr0279118-5-5-4
Average 86 stars, based on 1 article reviews
massarray platform - by Bioz Stars, 2026-09
86/100 stars

Images

Related Articles

other:

Article Title: BR-FDP-SKIN: Brazilian forensic DNA Skin phenotyping based on machine learning models
Article Snippet: ction NA Phenotyping (FDP) enables the prediction of different Externally Visible Characteristics (EVCs), air, and eye color, directly from genetic material (1).. The inference of these traits using a limited set of tide Polymorphisms (SNPs) is extremely valuable in forensic investigations, aiding in the identification dividuals at crime scenes or among victims of mass disasters (2; 3; 4).. Multiple studies have mapped ted with hair, eye, and skin color (2; 5; 6; 7; 8; 9; 10; 11; 12; 13; 14; 15; 16).

Article Title: Identification of a Novel Genetic Variant responsible for Familial Atrial Fibrillation.
Article Snippet: This is a PDF of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability.. This version will undergo additional copyediting, typesetting and review before it is published in its final form.. As such, this version is no longer the Accepted Manuscript, but it is not yet the definitive Version of Record; we are providing this early version to give early visibility of the article.

Article Title: Analysis of MIR155HG gene polymorphisms and ulcerative colitis susceptibility in the Chinese Han Population
Article Snippet: Four single nucleotide polymorphisms (SNPs) of MIR155HG (rs1893650, rs2282471, rs2829803, and rs2829806) were genotyped using the Sequenom MassARRAY platform.

Variant Assay:

Article Title:
Article Snippet: .. OHSU: Oregon Health & Science University; MassARRAY: Sequenom MassARRAY iPLEX platform; 1KGP: 1000 Genomes Project. a 22 patient DNA samples; b 40 CCL samples and 22 patient DNA samples; c 40 CCL samples; d 40 CCL samples and 6 patient DNA samples analyzed for a single variant in RYR1 ; e 6 patient DNA samples analyzed for 34 variants in RYR1 . ..

DNA Purification:

Article Title: Integrating genetic and lifestyle determinants in a risk prediction model for esophageal squamous cell carcinoma in Taiwan.
Article Snippet: .. Genomic DNA was extracted from peripheral blood using the Puregene DNA Purification Kit (Gentra Systems, Minneapolis, MN, USA) and the resulting DNA was dispensed into 96-well plates (ABgene Limited, Epsom, UK). and samples Samples with concentrations ≥2.5 ng/μl were genotyped using the Sequenom MassARRAY system (with call rate > 95%). ..

Next-Generation Sequencing:

Article Title:
Article Snippet: .. Accuracy studies were performed by comparing the genotypes of the variants determined by the OA-PGx panel with at least one of 2 reference genotyping methods, next-generation sequencing (NGS), and/or Sequenom MassARRAY iPLEX platform (MassARRAY). ..

Modification:

Article Title: Midlife insulin resistance and brain beta-amyloid accumulation as predictors of change in late-life cognitive function - A 20-year follow-up study.
Article Snippet: .. APOE genotype was defined with the MassARRAY System (Sequenom, San Diego, CA, USA) with a modified protocol (Jänis et al., 2004). ..



Similar Products

96
agena bioscience agena massarray methylation detection
Agena Massarray Methylation Detection, supplied by agena bioscience, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/massarray+methylation+detection/Methylation/ppr0552502-125-0-0
Average 96 stars, based on 1 article reviews
agena massarray methylation detection - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

90
Sequenom massarray methylation detection
A A negative correlation between ZNF334 <t>methylation</t> level and its mRNA expression (Pearson r = −0.53, R 2 = 0.28) B mRNA expression of ZNF334 in cancer and adjacent tissues of 213 liver cancer patients. C Western-blot diagram of ZNF334 expression in cancer and adjacent tissues of 12 liver cancer patients. D Methylation mass spectrum primers of ZNF334 promoter region and mass spectrometry detection product sequence (green indicates the EPIC chip probe cg07139762 site, which is in the ZNF334 promoter region; yellow indicates the <t>MassARRAY</t> methylation mass spectrometry detection sites, a total of 29). E Heat map of methylation level of ZNF334 promoter region in cancer and adjacent tissues of 25 patients with liver cancer. F The ratio of methylation degree of ZNF334 promoter in cancer and adjacent tissues (T/P) of 25 patients with liver cancer. G The average methylation degree of ZNF334 promoter in cancer and adjacent tissues of 25 patients with liver cancer. **** p < 0.0001.
Massarray Methylation Detection, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/massarray+methylation+detection/massarray+quantitative+methylation+analysis/pmc09085879-231-0-4
Average 90 stars, based on 1 article reviews
massarray methylation detection - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

96
agena bioscience massarray system methylation detection amplification pcr reaction
A A negative correlation between ZNF334 <t>methylation</t> level and its mRNA expression (Pearson r = −0.53, R 2 = 0.28) B mRNA expression of ZNF334 in cancer and adjacent tissues of 213 liver cancer patients. C Western-blot diagram of ZNF334 expression in cancer and adjacent tissues of 12 liver cancer patients. D Methylation mass spectrum primers of ZNF334 promoter region and mass spectrometry detection product sequence (green indicates the EPIC chip probe cg07139762 site, which is in the ZNF334 promoter region; yellow indicates the <t>MassARRAY</t> methylation mass spectrometry detection sites, a total of 29). E Heat map of methylation level of ZNF334 promoter region in cancer and adjacent tissues of 25 patients with liver cancer. F The ratio of methylation degree of ZNF334 promoter in cancer and adjacent tissues (T/P) of 25 patients with liver cancer. G The average methylation degree of ZNF334 promoter in cancer and adjacent tissues of 25 patients with liver cancer. **** p < 0.0001.
Massarray System Methylation Detection Amplification Pcr Reaction, supplied by agena bioscience, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/massarray+methylation+detection/Methylation/pm31002356-111-8-15
Average 96 stars, based on 1 article reviews
massarray system methylation detection amplification pcr reaction - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

96
agena bioscience agena massarray system methylation detection amplification pcr reaction
A A negative correlation between ZNF334 <t>methylation</t> level and its mRNA expression (Pearson r = −0.53, R 2 = 0.28) B mRNA expression of ZNF334 in cancer and adjacent tissues of 213 liver cancer patients. C Western-blot diagram of ZNF334 expression in cancer and adjacent tissues of 12 liver cancer patients. D Methylation mass spectrum primers of ZNF334 promoter region and mass spectrometry detection product sequence (green indicates the EPIC chip probe cg07139762 site, which is in the ZNF334 promoter region; yellow indicates the <t>MassARRAY</t> methylation mass spectrometry detection sites, a total of 29). E Heat map of methylation level of ZNF334 promoter region in cancer and adjacent tissues of 25 patients with liver cancer. F The ratio of methylation degree of ZNF334 promoter in cancer and adjacent tissues (T/P) of 25 patients with liver cancer. G The average methylation degree of ZNF334 promoter in cancer and adjacent tissues of 25 patients with liver cancer. **** p < 0.0001.
Agena Massarray System Methylation Detection Amplification Pcr Reaction, supplied by agena bioscience, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/massarray+methylation+detection/Methylation/pm31002356-111-7-15
Average 96 stars, based on 1 article reviews
agena massarray system methylation detection amplification pcr reaction - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

Image Search Results


A A negative correlation between ZNF334 methylation level and its mRNA expression (Pearson r = −0.53, R 2 = 0.28) B mRNA expression of ZNF334 in cancer and adjacent tissues of 213 liver cancer patients. C Western-blot diagram of ZNF334 expression in cancer and adjacent tissues of 12 liver cancer patients. D Methylation mass spectrum primers of ZNF334 promoter region and mass spectrometry detection product sequence (green indicates the EPIC chip probe cg07139762 site, which is in the ZNF334 promoter region; yellow indicates the MassARRAY methylation mass spectrometry detection sites, a total of 29). E Heat map of methylation level of ZNF334 promoter region in cancer and adjacent tissues of 25 patients with liver cancer. F The ratio of methylation degree of ZNF334 promoter in cancer and adjacent tissues (T/P) of 25 patients with liver cancer. G The average methylation degree of ZNF334 promoter in cancer and adjacent tissues of 25 patients with liver cancer. **** p < 0.0001.

Journal: Cell Death & Disease

Article Title: DNA hypermethylation modification promotes the development of hepatocellular carcinoma by depressing the tumor suppressor gene ZNF334

doi: 10.1038/s41419-022-04895-6

Figure Lengend Snippet: A A negative correlation between ZNF334 methylation level and its mRNA expression (Pearson r = −0.53, R 2 = 0.28) B mRNA expression of ZNF334 in cancer and adjacent tissues of 213 liver cancer patients. C Western-blot diagram of ZNF334 expression in cancer and adjacent tissues of 12 liver cancer patients. D Methylation mass spectrum primers of ZNF334 promoter region and mass spectrometry detection product sequence (green indicates the EPIC chip probe cg07139762 site, which is in the ZNF334 promoter region; yellow indicates the MassARRAY methylation mass spectrometry detection sites, a total of 29). E Heat map of methylation level of ZNF334 promoter region in cancer and adjacent tissues of 25 patients with liver cancer. F The ratio of methylation degree of ZNF334 promoter in cancer and adjacent tissues (T/P) of 25 patients with liver cancer. G The average methylation degree of ZNF334 promoter in cancer and adjacent tissues of 25 patients with liver cancer. **** p < 0.0001.

Article Snippet: MassARRAY methylation detection technology (Sequenom, USA) performed by CapitalBio Technology (Shanghai, China) was used to detect the methylation level of ZNF334 promoter (human) in carcinoma and paracancerous tissues of 25 HCC patients and Zfp334 promoter (mice) in treatment and control group.

Techniques: Methylation, Expressing, Western Blot, Mass Spectrometry, Sequencing